Seed and Series A

In order to comply with Anti-Money Laundering (AML) regulations, Balanced Pharma is required to provide the following information for each investor: Social Security Number (for a person) or Tax Identification Number (for an entity), mailing address, and contact phone number.

We apologize for any inconvenience that this may cause, but the collection of this information is mandated by federal authorities.  Please complete the following fields and click Submit Form.  If you have any questions, please contact us.  Thank you.

Please acknowledge the following to continue

I acknowledge that all Balanced Pharma Incorporated (BPI) products are currently in development and have not been evaluated or approved by FDA or any other regulatory body.

Products mentioned on this website are not available for sale, distribution, or use in any jurisdiction.